BC Platforms Acquires Medexprim, Paving the Way for Global Leadership in Real-World Data and Real-World Evidence Analytics

Our portfolio company, BC Platforms (BCP) announces the acquisition of Medexprim , a leading European Real-World Data company. The acquisition significantly expands BC Platforms’ ability to provide global biopharma partners with secure access to Real-World clinical and imaging Data assets across Europe. Medexprim bridges leading hospitals and pharmaceutical companies, with a major footprint in France, Germany and Spain. The company structures Real-World clinical and imaging Datasets to accelerate precision medicine, with a focus on oncology, neurology, cardiology and rare diseases.

Our goal is to build the world’s largest health data network for precision medicine and become a global leader in our field. With Medexprim’s capabilities and assets, we can now offer our partners seamless access to Real-World Data from every major EU-5 country. In addition to our networks in Asia and North America, this makes us an actual European leader in Real-World Data and Evidence.

said Tero Silvola, CEO of BC Platforms.

Access to their full press release here